Related Experiment Video
Updated: Dec 18, 2025
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Treatment and research lines for the patient with COVID-19. What do we have and where are we going?
1Servicio de Neumología, IIS-Fundación Jiménez Díaz - ISCIII-CIBERES, Madrid, Spain.
Abstract:
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) represents the most significant global public health crisis of this generation. From the beginning of the pandemic, several publications and on-line resources about different treatment lines have been done, and development effort in response to the COVID-19 pandemic to investigate potential therapies is unprecedented. Unfortunately, until now, there is not enough evidence to recommend any specific anti-COVID19 treatment. Randomized clinical trials and high-quality evidence, even in the middle of a pandemic, are needed. We provide a review of the latest published literature on the therapeutic strategies and current investigational lines for SARS-CoV-2.
Insights
No specific treatment is currently recommended for Coronavirus disease 2019 (COVID-19). High-quality evidence from randomized clinical trials is crucial for identifying effective therapies against SARS-CoV-2.
Area of Science:
- Infectious Diseases
- Virology
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is a major global health crisis.
- Unprecedented research efforts have focused on identifying COVID-19 treatments.
- Currently, insufficient evidence supports specific anti-COVID-19 therapies.
Purpose of the Study:
- To review the latest published literature on therapeutic strategies for SARS-CoV-2.
- To summarize current investigational lines for COVID-19 treatment.
Main Methods:
- Literature review of published studies on SARS-CoV-2 therapeutics.
- Analysis of current research and clinical trials for COVID-19 treatments.
Main Results:
- A significant volume of research exists on potential COVID-19 treatments.
- Despite extensive efforts, definitive evidence for recommended treatments is lacking.
- The need for high-quality randomized clinical trials is emphasized.
Conclusions:
- No specific anti-COVID-19 treatment is currently recommended due to insufficient evidence.
- Further high-quality research, including randomized clinical trials, is essential.
- Continued investigation into therapeutic strategies for SARS-CoV-2 is necessary.
More Related Videos
Related Concept Videos
01:24Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:29Microorganisms in Medicine and Therapeutics
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:13Controls in Experiments
01:29Theoretical Approaches to Psychological Disorder
Biological approach
The biological approach posits that internal, organic factors are the primary causes of such disorders. This perspective emphasizes brain structure and function, genetic predispositions, and neurotransmitter imbalances. For example, schizophrenia has been associated with both genetic...